Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03

Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational drug NOV03 (perfluorohexyloctane) as a first-in-class eye drop with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD). The companies announced statistically significant topline data from the first Phase 3 trial (GOBI trial) in April 2021.

“The findings from this second Phase 3 trial reinforce the results of the first Phase 3 trial and further supports the efficacy and safety profile of NOV03 as a potential important new treatment option for the millions of people living with dry eye disease associated with MGD,” said Joseph C. Papa, chairman and CEO, Bausch Health. “These results mark another important milestone in bringing NOV03 to market as a potential first-in-class treatment, and we anticipate filing a New Drug Application to the U.S. Food and Drug Administration in 2022.”

The MOJAVE trial met both primary sign and symptom endpoints, and also met all of its secondary endpoints, showing statistically significant improvements in each of the signs and symptoms of DED associated with MGD that were evaluated.

“We are extremely pleased by the consistency of the results, which reaffirm the safety and efficacy results for this investigational drug previously demonstrated in a Phase 2 trial and the first Phase 3 trial. This underscores the potential impact NOV03 could have, if approved, in addressing an unmet medical need for the millions of patients with dry eye disease associated with MGD,” said Christian Roesky, Ph.D., CEO, Novaliq.

The clinical development program for NOV03 is expected to conclude with an ongoing multi-center, open-label, single-arm, 12-month safety extension trial (KALAHARI).

Click HERE for the full press release.

Related:

Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Featured Posts

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Learn More

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more

RBC Partners with CNIB Frontier Accessibility to Improve Accessibility for Canadians

RBC has partnered with CNIB Frontier Accessibility to offer BlindSquare, the world’s most widely used accessible GPS app developed for people who are blind or partially sighted, at more than 305 RBC branches across Canada.

Read more

OPTI Munich 2022 Celebrates Its Return

SWV Strategy with Vision routinely provides perspectives on major international trade shows. Here is their report on Opti Munich.

Read more

STRUKTUR Eyewear Receives Award at 100% Optical Trade Fair in London

From April 23 to 25, 2022, the 100% Optical exhibition was held in London. On April 23, STRUKTUR eyewear won the award for the unisex model of the year at the Love Eyewear Award ceremony.

Read more

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Learn More

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read More

RBC Partners with CNIB Frontier Accessibility to Improve Accessibility for Canadians

RBC has partnered with CNIB Frontier Accessibility to offer BlindSquare, the world’s most widely used accessible GPS app developed for people who are blind or partially sighted, at more than 305 RBC branches across Canada.

Read More

OPTI Munich 2022 Celebrates Its Return

SWV Strategy with Vision routinely provides perspectives on major international trade shows. Here is their report on Opti Munich.

Read More

STRUKTUR Eyewear Receives Award at 100% Optical Trade Fair in London

From April 23 to 25, 2022, the 100% Optical exhibition was held in London. On April 23, STRUKTUR eyewear won the award for the unisex model of the year at the Love Eyewear Award ceremony.

Read More

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Learn More

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more

RBC Partners with CNIB Frontier Accessibility to Improve Accessibility for Canadians

RBC has partnered with CNIB Frontier Accessibility to offer BlindSquare, the world’s most widely used accessible GPS app developed for people who are blind or partially sighted, at more than 305 RBC branches across Canada.

Read more

OPTI Munich 2022 Celebrates Its Return

SWV Strategy with Vision routinely provides perspectives on major international trade shows. Here is their report on Opti Munich.

Read more

STRUKTUR Eyewear Receives Award at 100% Optical Trade Fair in London

From April 23 to 25, 2022, the 100% Optical exhibition was held in London. On April 23, STRUKTUR eyewear won the award for the unisex model of the year at the Love Eyewear Award ceremony.

Read more

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Learn More

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more

RBC Partners with CNIB Frontier Accessibility to Improve Accessibility for Canadians

RBC has partnered with CNIB Frontier Accessibility to offer BlindSquare, the world’s most widely used accessible GPS app developed for people who are blind or partially sighted, at more than 305 RBC branches across Canada.

Read more

OPTI Munich 2022 Celebrates Its Return

SWV Strategy with Vision routinely provides perspectives on major international trade shows. Here is their report on Opti Munich.

Read more

STRUKTUR Eyewear Receives Award at 100% Optical Trade Fair in London

From April 23 to 25, 2022, the 100% Optical exhibition was held in London. On April 23, STRUKTUR eyewear won the award for the unisex model of the year at the Love Eyewear Award ceremony.

Read more